{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:10:21Z","timestamp":1768335021453,"version":"3.49.0"},"reference-count":48,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Sarcopenic obesity (SO) is a complex pathological condition characterized by the simultaneous presence of excessive adipose tissue and the loss of muscle mass and strength. This combination leads to an increased risk of metabolic, cardiovascular, and functional complications. In recent years, there has been growing interest in the use of microRNAs (miRNA) as biomarkers capable of detecting early changes in body composition and predicting the progression of SO. MiRNAs are small noncoding RNA molecules that play a key role in regulating gene expression and cellular pathways related to inflammation, metabolism, and muscle trophism. This article summarizes current knowledge about miRNAs expression in patients with sarcopenic obesity, their regulatory functions, and their potential use in diagnostics and therapy.<\/jats:p>","DOI":"10.33549\/physiolres.935755","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:34:05Z","timestamp":1768311245000},"page":"S65","source":"Crossref","is-referenced-by-count":0,"title":["The Potential of MicroRNAs in the Context of Sarcopenic Obesity"],"prefix":"10.33549","author":[{"given":"N","family":"Chobolov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"\u0160vagera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Stejskal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bu\u017ega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19169","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1.\tWalpole SC, Prieto-Merino D, Edwards P, Cleland J, Stevens G, Roberts I. The weight of nations: an estimation of adult human biomass. BMC Public Health 2012;12:439. https:\/\/doi.org\/10.1186\/1471-2458-12-439","DOI":"10.1186\/1471-2458-12-439"},{"key":"ref1","unstructured":"2.\tMatoulek M, Sva\u010dina \u0160, Lajka J. V\u00fdskyt obezity a jej\u00edch komplikac\u00ed v \u010cesk\u00e9 republice. Vnitr Lek 2010;56:1019-1027."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.\tBuchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-1737. https:\/\/doi.org\/10.1001\/jama.292.14.1724","DOI":"10.1001\/jama.292.14.1724"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.\tFried M, Yumuk V, Oppert JM, Scopinaro N, Torres A, Weiner R, Yashkov Y, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg 2014;24:42-55. https:\/\/doi.org\/10.1007\/s11695-013-1079-8","DOI":"10.1007\/s11695-013-1079-8"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5.\tSchauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med 2017;376:641-651. https:\/\/doi.org\/10.1056\/NEJMoa1600869","DOI":"10.1056\/NEJMoa1600869"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.\tCruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, Cooper C, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019;48:16-31. https:\/\/doi.org\/10.1093\/ageing\/afy169","DOI":"10.1093\/ageing\/afz046"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7.\tChoi KM. Sarcopenia and Sarcopenic Obesity. Endocrinol Metab 2013;28:86-89. https:\/\/doi.org\/10.3803\/EnM.2013.28.2.86","DOI":"10.3803\/EnM.2013.28.2.86"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8.\tKohara K. Sarcopenic obesity in aging population: current status and future directions for research. Endocrine 2014;45:15-25. https:\/\/doi.org\/10.1007\/s12020-013-9992-0","DOI":"10.1007\/s12020-013-9992-0"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9.\tPark SH, Park JH, Song PS, Kim DK, Kim KH, Seol SH, Kim HK, et al. Sarcopenic obesity as an independent risk factor of hypertension. J Am Soc Hypertens 2013;7:420-425. https:\/\/doi.org\/10.1016\/j.jash.2013.06.002","DOI":"10.1016\/j.jash.2013.06.002"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10.\tKohara K, Ochi M, Tabara Y, Nagai T, Igase M, Miki T. Arterial stiffness in sarcopenic visceral obesity in the elderly: J-SHIPP study. Int J Cardiol 2012;158:146-148. https:\/\/doi.org\/10.1016\/j.ijcard.2012.04.033","DOI":"10.1016\/j.ijcard.2012.04.033"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11.\tBaek SJ, Nam GE, Han KD, Choi SW, Jung SW, Bok AR, Kim YH, et al. Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008-2010 Korea National Health and Nutrition Examination Survey. J Endocrinol Invest 2014;37:247-260. https:\/\/doi.org\/10.1007\/s40618-013-0011-3","DOI":"10.1007\/s40618-013-0011-3"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12.\tHong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study. Hepatology 2014;59:1772-1778. https:\/\/doi.org\/10.1002\/hep.26716","DOI":"10.1002\/hep.26716"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13.\tKim TN, Park MS, Lim KI, Choi HY, Yang SJ, Yoo HJ, Kang HJ, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study. Clin Endocrinol (Oxf) 2013;78:525-532. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04433.x","DOI":"10.1111\/j.1365-2265.2012.04433.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14.\tWaters DL, Hale L, Grant AM, Herbison P, Goulding A. Osteoporosis and gait and balance disturbances in older sarcopenic obese New Zealanders. Osteoporos Int 2010;21:351-357. https:\/\/doi.org\/10.1007\/s00198-009-0947-5","DOI":"10.1007\/s00198-009-0947-5"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15.\tBaumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly. Obes Res 2004;12:1995-2004. https:\/\/doi.org\/10.1038\/oby.2004.250","DOI":"10.1038\/oby.2004.250"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16.\tDowling L, Duseja A, Vilaca T, Walsh JS, Goljanek-Whysall K. MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review. J Cachexia Sarcopenia Muscle 2022;13:68-85. https:\/\/doi.org\/10.1002\/jcsm.12878","DOI":"10.1002\/jcsm.12878"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17.\tPedraza-V\u00e1zquez G, Mena-Montes B, Hern\u00e1ndez-\u00c1lvarez D, G\u00f3mez-Verjan JC, Toledo-P\u00e9rez R, L\u00f3pez-Teros MT, K\u00f6nigsberg M, et al. A low-intensity lifelong exercise routine changes miRNA expression in aging and prevents osteosarcopenic obesity by modulating inflammation. Arch Gerontol Geriatr 2023;105:104856. https:\/\/doi.org\/10.1016\/j.archger.2022.104856","DOI":"10.1016\/j.archger.2022.104856"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18.\tChen J, Jia S, Guo C, Fan Z, Yan W, Dong K. Research Progress on the Effect and Mechanism of Exercise Intervention on Sarcopenia Obesity. Clin Interv Aging 2024;19:1407-1422. https:\/\/doi.org\/10.2147\/CIA.S473083","DOI":"10.2147\/CIA.S473083"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19.\tWilhelmsen A, Tsintzas K, Jones SW. Recent advances and future avenues in understanding the role of adipose tissue cross talk in mediating skeletal muscle mass and function with ageing. GeroScience 2021;43:85-110. https:\/\/doi.org\/10.1007\/s11357-021-00322-4","DOI":"10.1007\/s11357-021-00322-4"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"20.\tPapadopoulos KI, Papadopoulou A, Aw TC. MicroRNA-155 mediates endogenous angiotensin II type 1 receptor regulation: implications for innovative type 2 diabetes mellitus management. World J Diabetes 2023;14:1334-1340. https:\/\/doi.org\/10.4239\/wjd.v14.i9.1334","DOI":"10.4239\/wjd.v14.i9.1334"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21.\tGrieb A, Schmitt A, Fragasso A, Widmann M, Maturana FM, Burgstahler C, Erz G, et al. Skeletal Muscle MicroRNA Patterns in Response to Exercise. Biomolecules 2023;13:884. https:\/\/doi.org\/10.3390\/biom13060884","DOI":"10.3390\/biom13060884"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22.\tMazurkiewicz \u0141, Czernikiewicz K, Grygiel-G\u00f3rniak B. Immunogenetic Aspects of Sarcopenic Obesity. Genes 2024;15:206. https:\/\/doi.org\/10.3390\/genes15020206","DOI":"10.3390\/genes15020206"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"23.\tKhanal P, Williams AG, He L, Stebbings GK, Onambele-Pearson GL, Thomis M, Degens H, Morse CI. Sarcopenia, Obesity, and Sarcopenic Obesity: Relationship with Skeletal Muscle Phenotypes and SNPs. J Clin Med 2021;10:4933. https:\/\/doi.org\/10.3390\/jcm10214933","DOI":"10.3390\/jcm10214933"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"24.\tJin H, Yoo HJ, Kim YA, Lee JH, Lee Y, Kwon S-H, Seo YJ, et al. Unveiling genetic variants for age-related sarcopenia: GWAS in Korean cohorts. Sci Rep 2022;12:3501. https:\/\/doi.org\/10.1038\/s41598-022-07567-9","DOI":"10.1038\/s41598-022-07567-9"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"25.\tTeodori L, Costa A, Campanella L, Albertini MC. Immuno-Related MicroRNAs and Muscle Atrophy. Front Physiol 2019;9:1926. https:\/\/doi.org\/10.3389\/fphys.2018.01926","DOI":"10.3389\/fphys.2018.01926"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.\tvan Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007;316:575-579. https:\/\/doi.org\/10.1126\/science.1139089","DOI":"10.1126\/science.1139089"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"27.\tMcCarthy JJ. MicroRNA-206: the skeletal muscle-specific myomiR. Biochim Biophys Acta 2008;1779:682-691. https:\/\/doi.org\/10.1016\/j.bbagrm.2008.03.001","DOI":"10.1016\/j.bbagrm.2008.03.001"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"28.\tChen J-F, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang D-Y. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006;38:228-233. https:\/\/doi.org\/10.1038\/ng1725","DOI":"10.1038\/ng1725"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"29.\tNielsen S, Scheele C, Yfanti C, \u00c5kerstr\u00f6m T, Nielsen AR, Pedersen BK, Laye MJ. Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. J Physiol 2010;588:4029-4037. https:\/\/doi.org\/10.1113\/jphysiol.2010.189860","DOI":"10.1113\/jphysiol.2010.189860"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"30.\tCaria ACI, Nonaka CKV, Pereira CS, Soares MBP, Macambira SG, de Freitas Souza BS. Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity. Int J Mol Sci 2018;19:3608. https:\/\/doi.org\/10.3390\/ijms19113608","DOI":"10.3390\/ijms19113608"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"31.\tCarrer M, Liu N, Grueter CE, Williams AH, Frisard MI, Hulver MW, Bassel-Duby R, Olson EN. Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. Proc Natl Acad Sci U S A 2012;109:15330-15335. https:\/\/doi.org\/10.1073\/pnas.1207605109","DOI":"10.1073\/pnas.1207605109"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"32.\tPan D, Mao C, Quattrochi B, Friedline RH, Zhu LJ, Jung DY, Kim JK, Lewis B, Wang YX. MicroRNA-378 controls classical brown fat expansion to counteract obesity. Nat Commun 2014;5:4725. https:\/\/doi.org\/10.1038\/ncomms5725","DOI":"10.1038\/ncomms5725"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"33.\tNajafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, N\u00e4\u00e4r AM. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010;328:1566-1569. https:\/\/doi.org\/10.1126\/science.1189123","DOI":"10.1126\/science.1189123"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"34.\tPickering C, Kiely J. ACTN3: More than just a gene for speed. Front Physiol 2017;8:1080. https:\/\/doi.org\/10.3389\/fphys.2017.01080","DOI":"10.3389\/fphys.2017.01080"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"35.\tCho J, Lee I, Kang H. ACTN3 Gene and Susceptibility to Sarcopenia and Osteoporotic Status in Older Korean Adults. BioMed Research International 2017;2017:4239648. https:\/\/doi.org\/10.1155\/2017\/4239648","DOI":"10.1155\/2017\/4239648"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"36.\tDel Coso J, Hiam D, Houweling P, P\u00e9rez LM, Eynon N, Luc\u00eda A. More than a 'speed gene': ACTN3 R577X genotype, trainability, muscle damage, and the risk for injuries. Eur J Appl Physiol 2019;119:49-60. https:\/\/doi.org\/10.1007\/s00421-018-4010-0","DOI":"10.1007\/s00421-018-4010-0"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"37.\tJin H, Yoo HJ, Kim YA, Lee JH, Lee Y, Kwon SH, Seo YJ, et al. Unveiling genetic variants for age-related sarcopenia by conducting a genome-wide association study on Korean cohorts. Sci Rep 2022;12:3501. https:\/\/doi.org\/10.1038\/s41598-022-07567-9","DOI":"10.1038\/s41598-022-07567-9"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"38.\tLi Y, Yao M, Zhou Q, Cheng Y, Che L, Xu J, Xiao J, Shen Z, Bei Y. Dynamic regulation of circulating microRNAs during acute exercise and long-term exercise training in basketball athletes. Front Physiol 2018;9:282. https:\/\/doi.org\/10.3389\/fphys.2018.00282","DOI":"10.3389\/fphys.2018.00282"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"39.\tPedersen BK. Muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol (1985) 2009;107:1006-1014. https:\/\/doi.org\/10.1152\/japplphysiol.00734.2009","DOI":"10.1152\/japplphysiol.00734.2009"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"40.\tAlexander MS, Casar JC, Motohashi N, Vieira NM, Eisenberg I, Marshall JL, Gasperini MJ, et al. MicroRNA-486-dependent modulation of DOCK3\/PTEN\/AKT signaling pathways improves muscular dystrophy-associated symptoms. J Clin Invest 2014;124:2651-2667. https:\/\/doi.org\/10.1172\/JCI73579","DOI":"10.1172\/JCI73579"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"41.\tElia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MVG, Peterson KL, et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009;16:1590-1598. https:\/\/doi.org\/10.1038\/cdd.2009.153","DOI":"10.1038\/cdd.2009.153"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"42.\tKim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 2006;174:677-687. https:\/\/doi.org\/10.1083\/jcb.200603008","DOI":"10.1083\/jcb.200603008"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"43.\tKoutsoulidou A, Mastroyiannopoulos NP, Furling D, Uney JB, Phylactou LA. Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Dev Biol 2011;11:34. https:\/\/doi.org\/10.1186\/1471-213X-11-34","DOI":"10.1186\/1471-213X-11-34"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"44.\tKirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, Reid G. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 2011;6:e24145. https:\/\/doi.org\/10.1371\/journal.pone.0024145","DOI":"10.1371\/journal.pone.0024145"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"45.\tKirschner MB, Edelman JJ, Kao SC, Vallely MP, van Zandwijk N, Reid G. The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Front Genet 2013;4:94. https:\/\/doi.org\/10.3389\/fgene.2013.00094","DOI":"10.3389\/fgene.2013.00094"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"46.\tShah JS, Soon PS, Marsh DJ. Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs. PLoS One 2016;11:e0153200. https:\/\/doi.org\/10.1371\/journal.pone.0153200","DOI":"10.1371\/journal.pone.0153200"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"47.\tBecker N, Lockwood CM. Pre-analytical variables in miRNA analysis. Clin Biochem 2013;46:861-868. https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.02.015","DOI":"10.1016\/j.clinbiochem.2013.02.015"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"48.\tZendjabil M. Preanalytical, analytical and postanalytical considerations in circulating microRNAs measurement. Biochem Med (Zagreb) 2024;34:020501. https:\/\/doi.org\/10.11613\/BM.2024.020501","DOI":"10.11613\/BM.2024.020501"}],"container-title":["Physiological Research"],"original-title":[],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:34:10Z","timestamp":1768311250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2025\/74_S65.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":48,"URL":"https:\/\/doi.org\/10.33549\/physiolres.935755","relation":{},"ISSN":["0862-8408","1802-9973"],"issn-type":[{"value":"0862-8408","type":"print"},{"value":"1802-9973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}